Tigecycline for treatment of severe infections in intensive care: A drug use evaluation;Expérience de l'utilisation de la tigécycline dans le traitement des infections sévères en réanimation : Une étude pilote

Annales Francaises d'Anesthesie et de Reanimation

Volumn 29, Issue 5, 2010, Pages 354-360

  Jung, B ^a   Chanques, G ^a   Ghiba, M ^a   Cisse, M ^a   Rossel, N ^a   Perrigault, P F ^a   Souche, B ^a   Jean Pierre, H ^b   Jaber, S ^a  

^a HÔPITAL SAINT ELOI   (France)

^b HÔPITAL ARNAUD DE VILLENEUVE   (France)

Author keywords

Antibiotics; Multiresistant bacteria; Peritonitis; Pneumonia; Tigecycline

Indexed keywords

CIPROFLOXACIN; LINEZOLID; METRONIDAZOLE; PIPERACILLIN; TAZOBACTAM; TIGECYCLINE; ANTIINFECTIVE AGENT; MINOCYCLINE;

ABDOMINAL INFECTION; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CRITICALLY ILL PATIENT; DEMOGRAPHY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG TOLERANCE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; INTENSIVE CARE; MORTALITY; OBSERVATIONAL STUDY; PILOT STUDY; PROSPECTIVE STUDY; SENSITIVITY ANALYSIS; ANALOGS AND DERIVATIVES; BACTERIAL INFECTIONS; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; HUMANS; INTENSIVE CARE; MIDDLE AGED; MINOCYCLINE; PILOT PROJECTS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 77953542007     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annfar.2010.02.002     Document Type: Article

References (31)

1. Micek S.T. Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections. Clin Infect Dis 2007, S184-S190.
2. Stein G.E., Craig W.A. Tigecycline: a critical analysis. Clin Infect Dis 2006, 4:518-524.
3. Vasilev K., Reshedko G., Orasan R., Sanchez M., Teras J., Babinchak T., et al. A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae. J Antimicrob Chemother 2008, i29-40.
4. Leclerc T., Perez J.P., Debien B., Clapson P., Lenoir B. Traitement d'un choc septique à Acinetobacter baumannii multirésistant par tigécycline en association. Ann Fr Anesth Reanim 2007, 12:1056-1058.
5. Ellis-Grosse E.J., Babinchak T., Dartois N., Rose G., Loh E. The efficacy and safety of tigecycline in the treatment of skin and skin-structure infections: results of 2 double-blind phase 3 comparison studies with vancomycin-aztreonam. Clin Infect Dis 2005, S341-S353.
6. Babinchak T., Ellis-Grosse E., Dartois N., Rose G.M., Loh E. The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data. Clin Infect Dis 2005, S354-S367.
7. Oliva M.E., Rekha A., Yellin A., Pasternak J., Campos M., Rose G.M., et al. A multicenter trial of the efficacy and safety of tigecycline versus imipenem/cilastatin in patients with complicated intra-abdominal infections. BMC Infect Dis 2005, 88. [Study ID Numbers: 3074A1-301-WW; ClinicalTrials.gov Identifier: NCT00081744].
8. Swoboda S., Ober M., Hainer C., Lichtenstern C., Seiler C., Wendt C., et al. Tigecycline for the treatment of patients with severe sepsis or septic shock: a drug use evaluation in a surgical intensive care unit. J Antimicrob Chemother 2008, 3:729-733.
9. Le Gall J.R., Lemeshow S., Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. Jama 1993, 24:2957-2963.
10. Vincent J.L., de Mendonca A., Cantraine F., Moreno R., Takala J., Suter P.M., et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study Working group on " sepsis-related problems" of the European Society of Intensive Care Medicine. Crit Care Med 1998, 11:1793-1800.
11. Chanques G., Girard C., Pinzani V., Jaber S. Fatal pristinamycin-induced toxic epidermal necrolysis (Lyell's syndrome): difficulties in attributing causal association in the polymedicated intensive care unit patient. Acta Anaesthesiol Scand 2005, 5:721-722.
12. Constantin J.M., Roszyk L., Guerin R., Bannier F., Chartier C., Perbet S., et al. Tolérance de la caspofongine chez les patients de réanimation: étude prospective. Ann Fr Anesth Reanim 2008, 10:819-824.
13. Curcio D., Fernandez F., Cane A., Barcelona L., Stamboulian D. Indications of a new antibiotic in clinical practice: results of the tigecycline initial use registry. Braz J Infect Dis 2008, 3:198-201.
14. MacGowan A.P. Tigecycline pharmacokinetic/pharmacodynamic update. J Antimicrob Chemother 2008, i11-i16.
15. Burkhardt O., Rauch K., Kaever V., Hadem J., Kielstein J.T., Welte T. Tigecycline possibly underdosed for the treatment of pneumonia: a pharmacokinetic viewpoint. Int J Antimicrob Agents 2009.
16. Godreuil S, Rousseau-Didelot MN, Compan B, Darbas H, Marchandin H, Brun M, et al. Activité in vitro de la tigécycline vis-à-vis des entérobactéries résistantes aux céphalosporines de 3e génération, d'Acinetobacter et des Bacteroides du groupe fragilis: expérience du CHRU de Montpellier. 29e Réunion Interdisciplinaire de Chimiothérapie Anti Infectieuse, Paris, 2009.
17. Kelesidis T., Karageorgopoulos D.E., Kelesidis I., Falagas M.E. Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies. J Antimicrob Chemother 2008, 5:895-904.
18. Keeney D., Ruzin A., McAleese F., Murphy E., Bradford P.A. MarA-mediated overexpression of the AcrAB efflux pump results in decreased susceptibility to tigecycline in Escherichia coli. J Antimicrob Chemother 2008, 1:46-53.
19. Glupczynski Y., Berhin C., Nizet H. Antimicrobial susceptibility of anaerobic bacteria in Belgium as determined by E-test methodology. Eur J Clin Microbiol Infect Dis 2009, 3:261-267.
20. Malli E., Spiliopoulou I., Kolonitsiou F., Neocleous C., Klapsa D., Pantelidi K., et al. In vitro activity of tigecycline against gram-positive cocci: a multicentre study in Greece. J Antimicrob Chemother 2008, 5:1158-1160.
21. Werner G., Gfrorer S., Fleige C., Witte W., Klare I. Tigecycline-resistant Enterococcus faecalis strain isolated from a German intensive care unit patient. J Antimicrob Chemother 2008, 5:1182-1183.
22. Curcio D. Tigecycline for treating bloodstream infections: a critical analysis of the available evidence. Diagn Microbiol Infect Dis 2008, 3:358-359. author reply 60-1.
23. Rodvold K.A., Gotfried M.H., Cwik M., Korth-Bradley J.M., Dukart G., Ellis-Grosse E.J. Serum, tissue and body fluid concentrations of tigecycline after a single 100mg dose. J Antimicrob Chemother 2006, 6:1221-1229.
24. Anthony K.B., Fishman N.O., Linkin D.R., Gasink L.B., Edelstein P.H., Laudenbach E. Clinical and microbiological outcomes of serious infections with multidrug-resistant gram-negative organisms treated with tigecycline. Clin Infect Dis 2008, 4:567-570.
25. Martin C., Brun-Buisson C. Prise en charge initiale des états septiques graves de l'adulte et de l'enfant. Ann Fr Anesth Reanim 2007, 1:53-73.
26. Dupont H. Antibiothérapie probabiliste: arguments en faveur de la monothérapie. Ann Fr Anesth Reanim 2004, 23:631-635.
27. Dupont H., Carbon C., Carlet J. Monotherapy with a broad-spectrum beta-lactam is as effective as its combination with an aminoglycoside in treatment of severe generalized peritonitis: a multicenter randomized controlled trial The Severe Generalized Peritonitis Study Group. Antimicrob Agents Chemother 2000, 8:2028-2033.
28. Montravers P. [Antibiotic treatment of community-acquired peritonitis]. Ann Fr Anesth Reanim 2001, 411s-26s.
29. Jung B., Sebbane M., Chanques G., Courouble P., Cisse M., Perrigault P.F., et al. Pneumonies acquises sous ventilation mécanique: suivez les recommandations !. Ann Fr Anesth Reanim 2007, 10:844-849.
30. Boyadjiev I., Leone M., Garnier F., Albanèse J., Martin C. Prise en charge des pneumonies acquises sous ventilation mécanique. Ann Fr Anesth Reanim 2006, 7:761-772.
31. Entenza J.M., Moreillon P. Tigecycline in combination with other antimicrobials: a review of in vitro, animal and case report studies. Int J Antimicrob Agents 2009.